Michael Stull,Cristy Gupton
Michael Stull
No funding was received for the writing of this commentary. Stull is employed by Employers Health, which is an employer-founded and employer-led group-purchasing organization with a focus on managing contracts for self-funded plan sponsors ...
Paul C Langley,Sean D Sullivan
Paul C Langley
Objective: To propose a set of guidelines for use by health care organizations in the United States that seek useful, comparative clinical information and economic analysis on pharmaceutical products to make sound drug pu...
An Evaluation of the Effect of Pharmacist-Led Comprehensive Chemotherapy Consultation Services on Outpatient Appointment Adherence [0.03%]
药师主导的全面化疗咨询服务对门诊就诊依从性影响的评价研究论文
Ethan J Sebring,Melani A Rudisill,Jill S Bates et al.
Ethan J Sebring et al.
Background: The North Carolina Cancer Hospital at the University of North Carolina Medical Center serves patients with a variety of malignant conditions and discharges more than 130 patients each month. Processes to impro...
Bonnie C Greenwood
Bonnie C Greenwood
No funding supported the writing of this article. The author has nothing to disclose.
Michael T Rupp
Michael T Rupp
No funding supported the writing of this commentary. The author has nothing to disclose.
Brian Nightengale
Brian Nightengale
No funding supported the writing of this article. The author is an employee of AmerisourceBergen and leads its Good Neighbor Pharmacy program, which supports independent community pharmacy customers.
Troy Trygstad
Troy Trygstad
No funding was received for the writing of this commentary. The author has nothing to disclose.
Patient Medication Adherence Among Pharmacies Participating in a North Carolina Enhanced Services Network [0.03%]
北卡罗来纳州增强服务网络中参与药房的患者用药依从性
Benjamin Y Urick,Monali Bhosle,Joel F Farley
Benjamin Y Urick
Background: Improving medication adherence can reduce health care spending, and studies have demonstrated community pharmacists can positively affect adherence through the provision of enhanced services. The North Carolin...
Real-World Costs of Adverse Events in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer [0.03%]
非小细胞肺癌一线治疗中不良事件的经济负担
Nicole M Engel-Nitz,Michael P Johnson,Scott H Bunner et al.
Nicole M Engel-Nitz et al.
Background: Non-small cell lung cancer (NSCLC) is the most common form of lung cancer in the United States. Immunotherapies and cytotoxic chemotherapies used to treat advanced NSCLC carry a substantial risk of adverse eve...
Evolution of the Pharmacy Benefit Manager/Community Pharmacy Relationship: An Opportunity for Success [0.03%]
药房福利管理机构与社区药房关系的发展：通向成功的途径
Patty Taddei-Allen
Patty Taddei-Allen
No funding supported the writing of this commentary. The author has nothing to disclose.